España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Beam Therapeutics
BEAM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$26.59
-2.11
-7.35%
At close: -
$26.59
0.00
0.00%
After Hours: 7:53 PM EDT
Get Report
Comment
Beam Therapeutics (BEAM) Forecast
News
Earnings
Beam Therapeutics (BEAM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Beam Therapeutics (NASDAQ:BEAM) Stock
Beam Therapeutics Stock (NASDAQ: BEAM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 09, 2024
HC Wainwright & Co. Reiterates Buy on Beam Th...
Benzinga Newsdesk
Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains
Vandana Singh
Reported Sunday, Beam Therapeutics Showcases ...
Benzinga Newsdesk
Saturday, December 07, 2024
Beam Therapeutics Announced New Data from BEA...
Benzinga Newsdesk
Friday, December 06, 2024
Beam Therapeutics shares are trading higher. ...
Benzinga Newsdesk
Beam Therapeutics Has Appointed Sravan Emany ...
Benzinga Newsdesk
Wednesday, November 27, 2024
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Kaustubh Bagalkote
Monday, November 25, 2024
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
Vandana Singh
Thursday, November 07, 2024
HC Wainwright & Co. Reiterates Buy on Beam Th...
Benzinga Newsdesk
Wednesday, November 06, 2024
RBC Capital Maintains Sector Perform on Beam ...
Benzinga Newsdesk
Beam Therapeutics shares are trading higher a...
Benzinga Newsdesk
Breaking Down Beam Therapeutics: 5 Analysts Share Their Views
Benzinga Insights
This Clorox Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
Avi Kapoor
Leerink Partners Upgrades Beam Therapeutics t...
Benzinga Newsdesk
Tuesday, November 05, 2024
Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial
Vandana Singh
Beam Therapeutics To Present Hematology Franc...
Benzinga Newsdesk
Beam Therapeutics shares are trading lower in...
Benzinga Newsdesk
Patient In Beam Therapeutics' CRISPR Trial Fo...
Benzinga Newsdesk
Beam Therapeutics Ended Third Quarter 2024 Wi...
Benzinga Newsdesk
Beam Therapeutics Q3 2024 GAAP EPS $(1.77) Mi...
Benzinga Newsdesk
Monday, November 04, 2024
Beam Therapeutics's Earnings: A Preview
Benzinga Insights
Wednesday, October 16, 2024
Scotiabank Initiates Coverage On Beam Therape...
Benzinga Newsdesk
Thursday, September 19, 2024
RBC Capital Reiterates Sector Perform on Beam...
Benzinga Newsdesk
Tuesday, September 17, 2024
Jones Trading Initiates Coverage On Beam Ther...
Benzinga Newsdesk
Wednesday, September 11, 2024
Deep Dive Into Beam Therapeutics Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Stifel Maintains Buy on Beam Therapeutics, Ra...
Benzinga Newsdesk
Thursday, August 22, 2024
A Closer Look at 5 Analyst Recommendations For Beam Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Beam Th...
Benzinga Newsdesk
Wednesday, August 14, 2024
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
Vandana Singh
Wednesday, August 07, 2024
JP Morgan Maintains Overweight on Beam Therap...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Beam Thera...
Benzinga Newsdesk
RBC Capital Reiterates Sector Perform on Beam...
Benzinga Newsdesk
Tuesday, August 06, 2024
Beam Therapeutics Says Ended Q2 2024 With $1....
Benzinga Newsdesk
Beam Therapeutics Q2 2024 GAAP EPS $(1.11) Be...
Benzinga Newsdesk
Sunday, July 28, 2024
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, July 25, 2024
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Tuesday, July 23, 2024
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Beam Therapeutics shares are trading higher a...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Bea...
Benzinga Newsdesk
Friday, July 19, 2024
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Benzinga Neuro
Monday, July 15, 2024
Beam Therapeutics Has Initiated A Search For ...
Benzinga Newsdesk
Friday, July 12, 2024
Here's Why You Should Invest in Beam Therapeutics Now
Zacks
Thursday, June 27, 2024
Beam Therapeutics Begins Dosing in Phase I/II AATD Study
Zacks
Wednesday, June 26, 2024
Beam Therapeutics Announced The First Patient...
Benzinga Newsdesk
Friday, June 14, 2024
Beam Therapeutics Highlights Improved Manufac...
Benzinga Newsdesk
Tuesday, May 14, 2024
Beam Therapeutics Presents Data Highlighting ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Barclays Maintains Equal-Weight on Beam Thera...
Benzinga Newsdesk
Tuesday, May 07, 2024
Beam Therapeutics Ended Q1 2024 With $1.1B In...
Benzinga Newsdesk
Beam Therapeutics Q1 2024 GAAP EPS $(1.21) Be...
Benzinga Newsdesk
Tuesday, April 23, 2024
Expert Ratings For Beam Therapeutics
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch